IL18 and neoplasm: To restrict cytokines to the tumor vicinity, several studies have expressed IL-15, IL-12, or IL-18 as transgenes in CAR-T or NK-cells [27,28,29], or have loaded T-cells with IL-15 containing nano gel “backpacks” that are released following TCR activation [30].